|
Ireland, Sara J; Guzman, Alyssa A; O'Brien, Dina E et al. (2014) The effect of glatiramer acetate therapy on functional properties of B cells from patients with relapsing-remitting multiple sclerosis. JAMA Neurol 71:1421-8
|
|
Chen, Ding; Blazek, Monica; Ireland, Sara et al. (2014) Single dose of glycoengineered anti-CD19 antibody (MEDI551) disrupts experimental autoimmune encephalomyelitis by inhibiting pathogenic adaptive immune responses in the bone marrow and spinal cord while preserving peripheral regulatory mechanisms. J Immunol 193:4823-32
|
|
Cameron, Elizabeth M; Spencer, Sade; Lazarini, Jonathan et al. (2009) Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis. J Neuroimmunol 213:123-30
|
|
Stüve, O; Cravens, P D; Frohman, E M et al. (2009) Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy. Neurology 72:396-401
|
|
Harp, Christopher; Lee, Jane; Lambracht-Washington, Doris et al. (2007) Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection. J Neuroimmunol 183:189-99
|
|
Stuve, Olaf; Cravens, Petra D; Singh, Mahendra P et al. (2007) High incidence of post-lumbar puncture headaches in patients with multiple sclerosis treated with natalizumab: role of intrathecal leukocytes. Arch Neurol 64:1055-6
|
|
Stuve, Olaf; Marra, Christina M; Cravens, Petra D et al. (2007) Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions. Arch Neurol 64:169-76
|
|
Lambracht-Washington, Doris; O'Connor, Kevin C; Cameron, Elizabeth M et al. (2007) Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS. J Neuroimmunol 186:164-76
|
|
Stuve, Olaf; Marra, Christina M; Bar-Or, Amit et al. (2006) Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Arch Neurol 63:1383-7
|
|
Stuve, Olaf; Marra, Christina M; Jerome, Keith R et al. (2006) Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann Neurol 59:743-7
|
Showing the most recent 10 out of 12 publications
